Clinical trial · Observational
CancerenD24 Screening as an Aid to the Clinician for the Diagnosis of Cancer
Clinical Validation Of A Diagnostic Cancerend24 Screening As An Aid To The Clinician For The Diagnosis Of Cancer In Healthy Subjects Attending The ICPC
NCT06656728CI-TRIAL-00081893CancerenD24recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of the researchers is to test whether the CancerenD24 index, an algorithm based on the quantitative value of CD24, CD11b, clinical and laboratory characteristics, developed in the laboratory can help in the early detection of a malignant disease in a population of healthy subjects.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| Early Detection of Cancer | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Blood-based liquid biopsy | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Healthy subjects
- description
- Patients over the age of 40, without active cancer in the last 5 years, who come for a cancer screening (and sometimes other screenings) at the Integrated Cancer Prevention Center
- interventionNames
- Other: Blood-based liquid biopsy
Primary outcomes (1)
- measure
- Evaluation of the CancerenD24 Screening Assay
- timeFrame
- 3 years
- description
- To evaluate the "CancerenD24 screening assay" as an aid to physicians in diagnosing cancer in subjects aged 40 years and above
Secondary outcomes (5)
- measure
- Sensitivity and specificity of CancerenD24 versus the ground truth diagnosis
- timeFrame
- 3 years
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 40 Years
Show eligibility criteria text
Inclusion Criteria: 1. Completion of all medical exams and questionnaires including cancer diagnoses, demographic data and other epidemiologic information 2. Willing and able to sign an informed consent 3. Age ≥40 years Exclusion Criteria: 1. Age \< 40 years 2. Pregnancy or breastfeeding 3. Any type of fever 4. Any cancer active at study entry or up to 5 years prior to study entry 5. Polyposis syndromes 6. Inflammatory bowel disease 7. Unwilling or unable to provide informed consent
References
Publications (0)
Data not yet available
No reference posted for this study.